Tien-Li Lee - 15 Oct 2025 Form 4 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Nelson Sun, as Attorney-in-Fact
Issuer symbol
AARD
Transactions as of
15 Oct 2025
Transactions value $
$5,211
Form type
4
Filing time
16 Oct 2025, 18:14:38 UTC
Previous filing
16 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lee Tien-Li Chief Executive Officer, Director, 10%+ Owner C/O AARDVARK THERAPEUTICS, INC., 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO /s/ Nelson Sun, as Attorney-in-Fact 16 Oct 2025 0001940120

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AARD Common Stock Options Exercise $5.21K +1.23K +0.08% $4.24 1.54M 15 Oct 2025 Direct
holding AARD Common Stock 1.47M 15 Oct 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AARD Stock option (right to buy) Options Exercise $0 -1.23K -2.94% $0.00 40.6K 15 Oct 2025 Common Stock 1.23K $4.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.